Cargando…

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Hu, Jiangfeng, Song, Chenlin, Duan, Bensong, Zhang, Xiaoyan, Li, Dongliang, Zhu, Liang, Gao, Hengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101288/ https://www.ncbi.nlm.nih.gov/pubmed/30131857 http://dx.doi.org/10.18632/oncotarget.25888

Ejemplares similares

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B)
por: Hu, Jiangfeng, et al.
Publicado: (2019)

Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
por: Ni, Wen, et al.
Publicado: (2023)

Correction: fMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma
Publicado: (2016)

Correction to: Molecular pattern of lncRNAs in hepatocellular carcinoma
por: Mai, Haoming, et al.
Publicado: (2019)

Correction: LncRNA HCP5A promotes follicular thyroid carcinoma progression via miRNAs sponge
por: Liang, Leilei, et al.
Publicado: (2019)

Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer
por: Lin, Maosong, et al.
Publicado: (2017)

Correction to: LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway
por: He, Ke, et al.
Publicado: (2020)

Correction to: Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5
por: Ding, Gangqiang, et al.
Publicado: (2021)

miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation
por: Duan, Bensong, et al.
Publicado: (2017)

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2021)

Knockdown of lncRNA CCEPR suppresses colorectal cancer progression
por: Duan, Yuxia, et al.
Publicado: (2019)

Correction: LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a
Publicado: (2021)

LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway
por: Song, Xue-zhen, et al.
Publicado: (2020)

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2020)

Correction: LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond
por: Huang, Wanxu, et al.
Publicado: (2022)

Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2023)

Correction for: LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis
por: Tang, Jianwei, et al.
Publicado: (2021)

Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation
por: Wang, Tong-Hong, et al.
Publicado: (2017)

LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Publicado: (2023)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Correction to: Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC
por: Huang, Yiwen, et al.
Publicado: (2022)

Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
por: Shi, Xiuhui, et al.
Publicado: (2022)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2019)

Correction: Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma
por: Diao, Ruigang, et al.
Publicado: (2018)

Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018)

Correction: Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer
Publicado: (2019)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression
por: Ma, Danhui, et al.
Publicado: (2021)

Genetic Polymorphisms of lncRNA LINC00673 as Predictors of Hepatocellular Carcinoma Progression in an Elderly Population
por: Yuan, Lan-Ting, et al.
Publicado: (2022)

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Correction to: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
por: Xia, Wenfei, et al.
Publicado: (2020)

Correction to: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis
por: Hu, Yun-ping, et al.
Publicado: (2021)

Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro
por: Mo, Wenhui, et al.
Publicado: (2020)

lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
por: Gong, Xue, et al.
Publicado: (2022)

Correction to: LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
por: Wan, Peixing, et al.
Publicado: (2022)

LncRNA LINC01871 sponging miR-142-3p to modulate ZYG11B promotes the chemoresistance of colorectal cancer cells by inducing autophagy
por: Duan, Bensong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e47drgp5nqc517sf0c9df2hskb